AACE Diabetes Mellitus Clinical Practice Guidelines Task Force. Medical guidelines for the clinical practice for the management of diabetes mellitus. American Association of Clinical Endocrinologists website. Available at:
http://www.aace.com/pub/pdf/guidelines/DMGuidelines2007.pdf. Published 2007. Accessed February 12, 2010.
American Diabetes Association. American Diabetes Association position statement: standards of medical care in diabetes 2010.
Diabetes Care.
2010;33:S1-S99.
American Diabetes Association. Executive summary: standards of medical care in diabetes—2010.
Diabetes Care.
2010;33:S4-S10.
American Diabetes Association
website. Available at:
http://www.diabetes.org. Accessed February 12, 2010.
Chiasson JL. Acarbose for the prevention of diabetes, hypertension, and cardiovascular disease in subjects with impaired glucose tolerance: the study to prevent non-insulin-dependent diabetes mellitus (STOP-NIDDM) trial.
Endocr Pract.
2006;12(Suppl 1):25-30.
Continuing Medical Education. The Patient-Centered Practice website. Available at:
http://www.patientcenteredpractice.com/. Accessed August 14, 2010.
Endocrine Society website. Available at:
http://www.endo-society.org. Accessed February 12, 2010.
Gillies CL, Abrams KR, Lambert PC, et al. Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis.
Brit Med J.
2007;334:299-302.
Joslin Diabetes Center
website. Available at:
http://www.joslin.org/. Accessed August 14, 2010.
Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.
N Engl J Med. 2002;346(6):393-403.
Nissen SE, Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes.
N Engl J Med.
2007 May 21. [Epub ahead of print]
Orozco LJ, Buchleitner AM, Gimenez-Perez G, et al. Exercise or exercise and diet for preventing type 2 diabetes mellitus.
Cochrane Database Syst Rev.
2008;16;(3):CD003054.
11/29/2006 DynaMed's Systematic Literature Surveillance
http://www.dynamicmedical.com/what.php: Lindstrom J, Ilanne-Parikka P, Peltonen M, et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study.
Lancet. 2006;368(9548):1673-1679.
11/29/2006 DynaMed's Systematic Literature Surveillance
http://www.dynamicmedical.com/what.php: DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone Medication) Trial Investigators; Gerstein HC, Yusuf S, Bosch J, et al. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.
Lancet. 2006;368(9541):1096-1105.
10/12/2009 DynaMed Systematic Literature Surveillance
http://www.dynamicmedical.com/what.php: Crandall JP, Polsky S, Howard AA, et al. Alcohol consumption and diabetes risk in the Diabetes Prevention Program.
Am J Clin Nutr.
2009;90:595-601.
10/5/2010 DynaMed's Systematic Literature Surveillance
http://www.ebscohost.com/dynamed/what.php: Carter P, Gray LJ, Troughton J, Khunti K, Davies MJ. Fruit and vegetable intake and incidence of type 2 diabetes mellitus: systematic review and meta-analysis.
BMJ.
2010;341:c4229.
La información aquí suministrada complementa la atención recibida por su médico. De ninguna forma intenta sustituir el consejo de un professional medico. LLAME A SU MEDICO DE INMEDIATO SI PIENSA QUE PODRIA TENER UNA EMERGENCIA. Siempre busque consejo médico antes de comenzar un nuevo tratamiento o si tiene preguntas sobre una condición médica.